MyAverix Finance
US · Healthcare
Kalaris Therapeutics, Inc. (KLRS)
Biotechnology
Kalaris Therapeutics, Inc. (KLRS) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for KLRS
Kalaris Therapeutics, Inc. (KLRS) — FAQ
What is KLRS's P/E ratio?
The price-to-earnings (P/E) ratio for Kalaris Therapeutics, Inc. (KLRS) is 25.00 (data as of 2026-05-23).
Does Kalaris Therapeutics, Inc. pay a dividend?
Dividend yield is not available in the current snapshot for Kalaris Therapeutics, Inc. (KLRS). Check the MyAverix Finance app for the latest dividend data.
What sector is Kalaris Therapeutics, Inc. in?
Kalaris Therapeutics, Inc. (KLRS) is classified in the Healthcare sector (Biotechnology industry).
What exchange is KLRS listed on?
KLRS is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.